Andrew M. Bellizzi, MD


Co-Director of Immunopathology Laboratory
Co-Director of GI Pathology, Holden Comprehensive Cancer Ctr
Clinical Associate Professor of Pathology  - Anatomic Pathology

Contact Information

Primary Office: 5239-A Roy Carver Pavilion
Iowa City, IA 52242
Phone: 319-356-4436



BA, University of Notre Dame
BS, University of Notre Dame
MD, Northwestern University, Feinberg School of Medicine

Residency, Pathology, AP/CP, University of Virginia Health System
Fellowship, Gastrointestinal/Liver Pathology, The Ohio State University Medical Center

Licensure and Certifications

Anatomic and Clinical Pathology, American Board of Pathology

Research Summary

Interests: Diagnosis, classification, and etiopathogenesis of human disease (especially gastrointestinal, neuroendocrine, hereditary, liver, and pancreatobiliary).

Center, Program and Institute Affiliations

Holden Comprehensive Cancer Center

Selected Publications

Show All

Van Dyke T, Johlin F, Bellizzi A, Howe J.  Serous Cystadenocarcinoma of the Pancreas: Clinical Features and Management of a Rare Tumor..  Dig Surg.  2016 March. 33(3):240-248.

Lee L, Wu B, Banks P, Kadiyala V, Mehta S, Saltzman J, Thompson C, Bellizzi A.  Utility of commercial DNA analysis in detecting malignancy within pancreatic cysts.  JOP.  2014 March 10. 15(2):182-8.

Bellizzi A.  Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms.  Semin Diagn Pathol.  2013 November. 30(4):329-61.

Bellizzi A, Nardone G, Compare D, Bor S, Capanoglu D, Farrė R, Neumann H, Neurath M, Vieth M, Chen H, Chen X.  Tissue resistance in the normal and diseased esophagus.  Ann N Y Acad Sci.  2013 October. 1300(1):200-212.

Bellizzi A.  Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.  Adv Anat Pathol.  2013 September. 20(5):285-314.

Bellizzi A.  Immunohistochemistry in Gastroenterohepatopancreatobiliary Epithelial Neoplasia: Practical Applications, Pitfalls, and Emerging Markers.  Surg Pathol clin.  2013 September. 6(3):567-609.

Herrera A, Soriano G, Bellizzi A, Hornick J, Ho V, Ballen K, Baden L, Cutler C, Antin J, Soiffer R, Marty F.  Cord colitis syndrome in cord-blood stem-cell transplantation.  N Engl J Med.  2011 September. 365(9):815-24.

Wang X, Ouyang H, Yamamoto Y, Kumar P, Wei T, Dagher R, Vincent M, Lu X, Bellizzi A, Ho K, Crum C, Xian W, McKeon F.  Residual embryonic cells as precursors of a Barrett's-like metaplasia.  Cell.  2011 June. 145(7):1023-35.

Bellizzi A, LeGallo R, Boyd J, Iezzoni J.  Hepatocyte cytokeratin 7 expression in chronic allograft rejection.  Am J Clin Pathol.  2011 February. 135(2):238-44.

Bellizzi A, Bloomston M, Zhou X, Iwenofu O, Frankel W.  The mTOR pathway is frequently activated in pancreatic ductal adenocarcinoma and chronic pancreatitis.  Appl Immunohistochem Mol Morphol.  2010 October. 18(5):442-7.

Date Last Modified: 06/06/2016 - 13:17:48